Heart failure guidelines: What you need to know about the 2017 focused update

Lee Rodney Haselhuhn; Daniel J Brotman; Ilan Shor Wittstein

doi:10.3949/ccjm.86a.18022

Heart failure guidelines: What you need to know about the 2017 focused update

Cleve Clin J Med. 2019 Feb;86(2):123-139. doi: 10.3949/ccjm.86a.18022.

Authors

Lee Rodney Haselhuhn¹, Daniel J Brotman², Ilan Shor Wittstein³

Affiliations

¹ Division of General Internal Medicine, Johns Hopkins Hospitalist Program, Johns Hopkins Hospital, Baltimore, MD, USA. lhaselh1@jhmi.edu.
² Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
³ Departments of Medicine and Cardiology, Johns Hopkins University, Baltimore, MD, USA.

PMID: 30742582
DOI: 10.3949/ccjm.86a.18022

Abstract

The 2017 focused update of the 2013 ACC/AHA guideline on heart failure contains new and important recommendations on prevention, novel biomarker uses, heart failure with preserved ejection fraction (HFpEF), and comorbidities such as hypertension, iron deficiency, and sleep-disordered breathing. Potential implications for management of acute decompensated heart failure will also be explored.

Publication types

Review

MeSH terms

Biomarkers / analysis
Blood Pressure
Cardiology / standards*
Disease Management
Heart Failure* / blood
Heart Failure* / physiopathology
Humans
Mineralocorticoid Receptor Antagonists / therapeutic use
Natriuretic Peptide, Brain / blood
Practice Guidelines as Topic*
Referral and Consultation / standards*
Stroke Volume

Substances

Biomarkers
Mineralocorticoid Receptor Antagonists
Natriuretic Peptide, Brain